RNC Capital Management LLC Increases Stake in CVS Health Corporation $CVS

RNC Capital Management LLC increased its holdings in CVS Health Corporation (NYSE:CVS) by 1.6% during the 4th quarter, HoldingsChannel reports. The firm owned 815,930 shares of the pharmacy operator’s stock after buying an additional 12,790 shares during the period. CVS Health accounts for approximately 2.9% of RNC Capital Management LLC’s portfolio, making the stock its 7th largest position. RNC Capital Management LLC’s holdings in CVS Health were worth $64,752,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Caitong International Asset Management Co. Ltd increased its position in CVS Health by 407.2% in the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 281 shares during the last quarter. Ares Financial Consulting LLC bought a new stake in CVS Health in the fourth quarter worth $29,000. Corundum Trust Company INC bought a new stake in CVS Health in the third quarter worth $29,000. GoalVest Advisory LLC bought a new stake in CVS Health in the fourth quarter worth $32,000. Finally, Financial Consulate Inc. increased its position in CVS Health by 99.6% in the fourth quarter. Financial Consulate Inc. now owns 499 shares of the pharmacy operator’s stock worth $40,000 after purchasing an additional 249 shares during the last quarter. Institutional investors own 80.66% of the company’s stock.

Analysts Set New Price Targets

CVS has been the topic of a number of analyst reports. Sanford C. Bernstein upgraded shares of CVS Health from a “market perform” rating to an “outperform” rating and boosted their price objective for the company from $91.00 to $94.00 in a research report on Thursday, March 12th. Wolfe Research cut their price objective on shares of CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research report on Monday, March 2nd. Bank of America cut their price objective on shares of CVS Health from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Tuesday, January 27th. Argus cut their price objective on shares of CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a research report on Wednesday, January 28th. Finally, The Goldman Sachs Group boosted their price objective on shares of CVS Health from $95.00 to $97.00 and gave the company a “buy” rating in a research report on Thursday, February 12th. Twenty equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $95.05.

CVS Health Stock Down 0.0%

Shares of CVS opened at $82.06 on Tuesday. The firm has a market capitalization of $105.17 billion, a P/E ratio of 59.47, a P/E/G ratio of 0.86 and a beta of 0.60. CVS Health Corporation has a 12-month low of $58.35 and a 12-month high of $85.15. The company has a current ratio of 0.84, a quick ratio of 0.63 and a debt-to-equity ratio of 0.80. The firm has a fifty day moving average price of $76.32 and a 200-day moving average price of $77.96.

CVS Health (NYSE:CVS) last issued its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. The firm had revenue of $105.69 billion during the quarter, compared to analyst estimates of $103.67 billion. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The business’s revenue was up 8.2% on a year-over-year basis. During the same period in the previous year, the firm earned $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts expect that CVS Health Corporation will post 7.14 earnings per share for the current year.

CVS Health Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.2%. The ex-dividend date of this dividend was Thursday, April 23rd. CVS Health’s payout ratio is currently 192.75%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over?the?counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in?store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk?in medical clinics and HealthHUB locations that offer expanded clinical services.